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Quality in the Making
Overview—This paper considers the evolution of quality
evaluation efforts, tracing their development from early
initiatives to keep track of patients after surgery through
the various guidelines, surveys, and measurement tools
in use today. It looks at both quality assurance and
quality improvement strategies, highlighting the differ-
ent philosophies that guide them. The paper examines
the roles of purchasers, providers, consumers, and
governments in furthering a quality agenda. Both
regulatory and voluntary approaches are assessed.
The scope and depth of information about the quality
of health care have grown dramatically over the past ten
years. Both the public and the private sectors have in-
vested substantial resources in collecting, analyzing, and
reporting data. Yet fundamental questions remain about
the safety and appropriateness of the care delivered to
American consumers and the extent to which the quality
of that care is accurately measured and reported.
Many dedicated people are working to improve health
care quality through research and education. Numerous
quality assessment tools have been developed. Clinical
guidelines, practice protocols, and performance measures
are available from a variety of sources ranging from
professional societies to Medicare’s peer review organiza-
tions. But this collection of tools and methods does not
add up to one handy and widely accepted toolkit. There is
no agreed-upon model or rubric for thinking about raising
the level of quality across the whole tangled health care
system. Quality initiatives have focused mainly on
improving the knowledge and practice of individual
clinicians; systems issues have been raised but are only
beginning to be addressed. Quality programs also have
been generally grounded in an acute-care model, while
chronic care needs, increasingly prevalent, may require a
different approach. Moreover, to date, measurement has
been used primarily to evaluate quality rather than to
improve it.
Strategies to control and improve quality may rely
on market forces, regulatory authority, or professional-
ism. With market-based managed care possibly past its
heyday, market proponents promote the power of the
consumer. However, agreement on the ultimate reposi-
tory for quality-improvement authority—be it the
medical professions, the federal government, an ac-
knowledged body of experts, or an organization of
empowered consumers—is again elusive.
Key questions remain about two main thrusts of
quality-focused efforts in health care—quality assur-
ance (“Are we doing OK?”) and quality improvement
(“Are we getting better?”)—and about the role and
needs of consumers. Private purchasers, government at
the state and federal levels, and medical professionals
all have had a hand in developing, demanding, and
applying quality standards. To what extent have activi-
ties moved from measuring organizational behavior
(“How often does the infection control committee
meet?”) to measuring actual processes and outcomes
(“In what percentage of orthopedic procedures were
prophylactic antibiotics administered?”)? How is this
shift affecting responsibilities for data collection,
analysis, and application? To what degree are results
once held mostly in private now being disseminated
more publicly? Who is to pay for all these activities?
Many of the issues in improving quality relate to
organizational dynamics. How can roles and relationships
among clinicians and patients and payers and regulators
be coordinated? Can outmoded systems be redesigned to
build in quality, as recommended in the new Institute of
Medicine publication, Crossing the Quality Chasm? How
can reimbursement mechanisms be changed to reward
quality? How can the various purposes to which quality
information is put be reconciled?
Increasingly, consumers as well as purchasers are
expected to exert greater pressure for high-quality care.
What information about the performance of a health
plan or provider do they need to make appropriate
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choices? How much of this is available to them? Can
high-quality care be both delivered and demonstrated to
all concerned?
An understanding of the evolution of quality efforts
as well as the current tools and programs being used to
assure quality or to improve it may be useful as policy-
makers struggle with these difficult issues.
QUALITY ASSURANCE 
The roots of quality assurance efforts in hospitals go
back to Florence Nightingale in England. After her
Crimean War experiences, she dryly wrote in her 1859
book, Notes on Hospitals, “It may seem a strange
principle to enunciate as the very first requirement in a
hospital that it should do the sick no harm.” Fifty years
later in the United States, Ernest Codman, M.D., urged
the establishment of a “hospital standardization pro-
gram” designed to track patient treatment to determine
whether patients were helped or harmed.1 The Amer-
ican College of Surgeons worked on an early form of
such a program in 1917; in due course, it evolved into
today’s Joint Commission on the Accreditation of
Healthcare Organizations (JCAHO).
The process for measuring performance under the
hospital standardization program was one that still goes
on in some “morbidity and mortality” conferences
today: retrospective review and discussion among
medical colleagues. The underlying principle is that an
individual can learn from his own mistakes and those of
others and benefit as well from the advice of peers.
The modern conceptual framework for evaluating
patient care was conceived by Avedis Donabedian in
the 1960s and refined thereafter. It posits three compo-
nents of health care quality—structure, process, and
outcomes—that are both hierarchical and interdepen-
dent. That is, structure measures, such as the types of
equipment a hospital possesses or whether surgeons
are board-certified, are indicators of capability rather
than results but may be necessary prerequisites to
more patient-specific indicators. Process measures,
such as the percentage of heart attack patients for
whom beta-blockers are prescribed, may be used to
systematize treatment patterns across a population of
patients. Outcomes, the pinnacle of patient-focused
analysis, may be more difficult to pin down (How
much has John’s quality of life improved or de-
creased?) or to tie to a specific intervention (If Jane
begins a new pharmaceutical regimen, will it keep her
out of the hospital?). Outcomes may be only partially
or distantly attributable to clinical interventions. Or
they may be too long in coming; one would not, it has
been suggested, want to measure the number of
strokes that occur (long-term observation) rather than
the administration of blood pressure controls known to
reduce the likelihood of stroke.
Another factor that has favored process over out-
comes measures is the relative ease, or even feasibility,
of data collection. Information on process can fre-
quently be obtained from data collected for another
purpose, such as billing. Information on outcomes is far
more likely to exist only in the form of a paper patient
record.
Some have suggested that the Donabedian frame-
work may need refinement under a systems-based
approach to quality. For example, some structural
characteristics are relatively set, such as the land
available for expansion or the medical schools the
surgeons attended. Other indicators considered struc-
tural, such as the sophistication of the information
system or the organization of a physician’s office
operations, are more amenable to redesign.
As measurement standards evolved, institution-level
analysis moved beyond case review to look at data
reflecting entire caseloads. By focusing on a population
of patients, quality analysts could judge how well a
hospital treated a particular disease or condition. Hospi-
tal statistics were audited, measured against predeter-
mined criteria, and compared with national averages.
In an article about the development of quality
assurance systems, Martin D. Merry, M.D., has pointed
out some shortcomings. First, an audit, like an individ-
ual case review, is retrospective, a snapshot of perfor-
mance for a specified period in the past. It also lacks
motivational value past a certain point:
Since hospitals have tended to use “national averages”
as thresholds, such monitoring and evaluation states
conceptually that “no problem” exists as long as the
institutional rate is no worse than the average for peer
facilities . . . [T]raditional health care quality assess-
ment has had the unintended, and largely unrecog-
nized, effect of establishing performance not worse
than average as an implicit goal.2 (emphasis added)
Hospitals were the first focus of quality evaluation
efforts, but today health plans also are held to scrutiny.
JCAHO, the National Committee for Quality Assurance
(NCQA), and URAC/the American Accreditation
Healthcare Commission all accredit health plans and/or
components thereof (for example, a plan’s credentialing
process or nurse triage call center).
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Whatever the setting, two predominant lines of
inquiry are pursued: adherence to clinical criteria and
patient perceptions of care.
Performance Standards
Comparing provider performance to specified
standards may serve a variety of purposes, such as (a)
helping a physician to improve his or her own perfor-
mance, (b) showing a health plan which clinical areas
are most in need of attention, (c) guiding a purchaser’s
contracting decisions. The aim is to improve actual
clinical outcomes and—to the extent the results are
made known—to raise public awareness of perfor-
mance differences and the accountability that should be
attached to them. Proponents of making a provider’s or
plan’s performance public in a comparative “report
card” format expect to influence consumers to choose
those with the highest quality scores.
Since the same performance standards will not
necessarily serve all audiences equally well, different
categories have evolved, for example clinical guidelines
aimed at physicians and health plan performance
measures geared to purchasers and consumers.
Guidelines. Clinical practice guidelines are protocols
that guide a clinician in making diagnosis and treatment
decisions. Guidelines have been developed and are
available from a variety of sources ranging from hospi-
tal systems to medical specialty societies to consulting
firms, but there is no final arbitrator among competing
sources. A clinician may consult a source he already
respects, such as his specialty society, in a voluntary
effort to enhance his own skills. Choosing a source gets
to be a more daunting task as guidelines, decision
support tools, and reported research proliferate. As one
physician has observed, “doctors are on information
overload. And yet we have some excellent clinical
guidelines that nobody ever reads. If applied, they have
the potential to improve both clinical outcomes and
perhaps reduce health care costs.”3
It is presumed that both consulting and applying
guidelines on the spot will be facilitated as physicians
adopt hand-held computer technology, although they
will still be faced with competing guideline and software
sources. More importantly, if guideline-stocked personal
digital assistants are to be more than an updated pocket
card, there is also the challenge (in terms of both policy
and technology) of putting patient and institutional
records at the clinician’s fingertips.
The Agency for Healthcare Research and Quality
(AHRQ) is working to identify and disseminate informa-
tion about quality and outcomes of care. Originally
created to develop guidelines, the agency has evolved in
a more advisory direction. In addition to supporting and
conducting research to establish the science base for
improvements in clinical care, AHRQ also maintains—in
partnership with the American Medical Association and
the American Association of Health Plans—the Web-
based National Guideline Clearinghouse.
Guidelines may be evidence-based, derived from
expert consensus, or a combination of both. AHRQ, for
example, requires that all guidelines included in the
National Guideline Clearinghouse be supported by
creditable scientific research. A milestone of consensus
was recently marked by the announcement that five
Minnesota health plans (among them covering almost
all the state’s insured residents) have endorsed and will
employ standard treatment and prevention procedures
for 50 common ailments, such as back pain, high blood
pressure, and diabetes.
Guidelines are controversial because some view them
as a means of limiting a physician’s options or as a reason
to deny claims. “Cookbook medicine,” many have
muttered scornfully. Particularly contentious have been
length-of-stay norms for particular medical procedures,
produced by the consulting firm Milliman & Robertson,
which have prompted states and Congress to adopt
legislation forbidding insurance companies to require
“drive-through” (outpatient) births and mastectomies.
Under claims procedure rules promulgated by the U.S.
Department of Labor, health plans will be required to give
claimants detailed information about any guidelines relied
upon in making an “adverse” benefit or claims determina-
tion (that is, denying payment).
Performance Measures. With both cost and quality in
mind, accrediting bodies, health plans, hospital systems,
and others have tried to standardize certain dimensions of
clinical practice by prescribing specific behaviors that can
be measured. What is measured is primarily process, but
process that has been shown to be associated with positive
outcomes. For example, annual mammography for
women over 50 does not in itself cure or prevent breast
cancer but, by promoting early identification and diagno-
sis, can lead to earlier intervention and thus an improved
chance of successful treatment.
The acknowledged leader among these mostly
process-oriented measurement sets is NCQA’s HEDIS
(Health Plan Employer Data and Information Set).
HEDIS is a continually evolving set of performance
measures, currently numbering 56, with a range of
emphasis, from primary prevention (such as the percent-
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age of children immunized for chicken pox) to screen-
ing (for example, cervical cancer screening tests) to
specified physiological outcomes (such as the percent-
age of cardiovascular patients with LDL-C levels under
130 mg./dl. after 60 days).
HEDIS measures are applied at the health plan level.
Participation is voluntary for commercial plans, though
some employers make it a contract specification.
Medicare+Choice plans and some Medicaid plans are
required to collect and report HEDIS data on some
subset of measures. It has been suggested that concen-
trating on a specified number of measures encourages
plans to “perform to the test” to the detriment of quality
considerations that are not being measured.
NCQA estimates that more than 90 percent of health
plans in the United States use HEDIS data for quality
assessment.4 Employing a common measurement set is
the foundation for meaningful comparison among plans.
Refining HEDIS over time, NCQA’s Committee on
Performance Measurement can respond to current health
care concerns, as is demonstrated by a look at the mea-
sures new in 2000: chlamydia screening in women,
controlling high blood pressure, use of appropriate
medications for people with asthma, and management of
menopause. Again, performing to the test may force
health plans to focus on the prescribed data set rather than
what most greatly benefits their particular population.
Large employers rely extensively on HEDIS data in
their own quality-promotion efforts. Consumers are less
likely to be aware of HEDIS, even where health plans
choose to make their scores public. The 1999 Survey of
Employer Health Benefits published by the Kaiser
Family Foundation and the Health Research and Educa-
tional Trust found that only 10 percent of workers in
firms offering a health maintenance organization
(HMO) or point-of-service plan cited HEDIS ratings as
important in choosing a plan.5 It should be noted,
however, that these figures do not give insight into
consumer weightings under different circumstances,
such as changing health status.
Though widely used, HEDIS cannot serve as a
measurement tool across the entire spectrum of health
care. It is a managed-care phenomenon, designed with
closed-panel HMOs in mind. With a definable total
population to serve as a denominator, percentages can
be calculated, such as the proportion of children in a
plan who received appropriate immunizations. In a fee-
for-service environment, a denominator must be
constructed—for example, the total number of two-
year-olds for whom appointments were scheduled—and
may be incomplete (for example, leaving out those who
never saw a doctor). Open-network plans such as
preferred provider organizations can make use of claims
data, but this will not permit them to determine, for
example, whether a physician has advised a patient to
quit smoking.
Perhaps the most significant limitation of perfor-
mance measures such as HEDIS is their application at
the health plan level. Employees rarely have free, or
even broad, choice among plans. Quality information
would be more personally valuable when the question
is “Who is the best surgeon for repairing an aortic
aneurysm?” or “Which hospital has the lowest infection
rates?” While some comparison among medical group
practices has been undertaken, making performance
information at the individual provider level publicly
available continues to raise strong resistance. Neverthe-
less, many believe that performance measures optimally
would furnish the data for public accountability of
clinicians and organizations and serve as the basis for
developing improvement strategies.
Patient Perceptions of Care
In the competitive environment of modern health
care, health plans and many providers have become
accustomed to surveying their own customers for
feedback on their health care experience. Like perfor-
mance standards, such surveys may also serve a variety
of purposes, including guidance on improving practice
conditions and procedures, generating marketing copy
aimed at insurance purchasers and potential members,
and demonstrating compliance with accrediting body
standards such as HEDIS or directives from the Health
Care Financing Administration (HCFA) and the states.
A salient difference between performance measures
and perception-of-care (also called “satisfaction”)
surveys is that the former are meant to be as objective
as possible, while the latter are by definition and intent
subjective. Only an individual’s own feelings can
respond to a question such as “Did the doctor explain
the treatment plan well enough for you to feel comfort-
able?” Time in the waiting room beyond the scheduled
hour of one’s appointment may overshadow the physi-
cian’s splendid credentials in a patient’s mind. And
most patients—despite growing use of the Internet and
barring egregious provider ineptitude—are not sophisti-
cated enough to judge subtle gradations of clinical
quality. So, in effect, process is being measured here as
well. In some cases, particularly when a patient has a
chronic or long-term condition, process may in fact be
a more important determinant than outcome. That is, the
way a physician helps a patient to live with and manage
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a condition that is never going to improve physiologi-
cally is a more realistic and significant quality indicator
than clinical improvement. Moreover, the patient’s
understanding of the illness may be one of the key
determinants of his or her prognosis.
Satisfaction survey instruments may be administered
to discrete populations, such as enrollees in a particular
health plan or employees of a particular company. An
instrument with wider application is the Consumer
Assessment of Health Plans Survey (CAHPS), developed
under cooperative a agreement among AHRQ, Harvard,
RAND, and the Research Triangle Institute. Adopted by
numerous sponsors and purchasers, including HCFA,
CAHPS was incorporated into HEDIS in 1999.
CAHPS includes questions relating to general
perceptions and specific consumer experiences and asks
about both the consumer’s health plan and his or her
individual providers. Its goal is “to provide an integrated
set of tested and standardized survey questionnaires and
accompanying report formats that can be used to collect
and report meaningful and reliable information from
health plan enrollees about their experiences” and
ultimately to assist consumers in choosing a health plan.6
The impact of satisfaction surveys is difficult to
assess. As noted above, consumers typically do not
have the broad range of health plan choices that a plan-
satisfaction comparison would seem to envision.
However, research sponsored by AHRQ found that
Washington state employees, with the uncommonly
broad choice of 20 health plans, made use of the
CAHPS performance report when it was provided to
them. Employees who used CAHPS information were
more likely than those who did not to switch plans and
to report that they were confident they had selected the
best plan for their situation.7
Critics have observed that the survey instrument’s
dual focus on experience with the health plan and the
individual provider can be confusing for consumers.
They also note that reporting is slow and question the
value of a months-old “snapshot.” Typically reported to
the health plan or the plan sponsor, survey data are not
always made available to consumers or providers. And,
while survey results may be used in a variety of ways by
health plans and providers, without consumer buy-in
(and cooperation in responding), they are difficult to
justify in terms of time and resources.
Even where consumer response is enthusiastic,
paying for a broad-based survey is a challenge. A
statewide survey conducted by the Minnesota Health
Data Institute in 1995 generated comparative data on 46
health plans in a variety of formats (such as comparisons
across all plans and among categories such as Medicare
HMOs). The same survey instrument was used across
Medicare, Medicaid, state employee, and privately
insured populations. The results were distributed with
copies of 60 daily newspapers across the state and made
available on the Internet and in public libraries. The plan
at the time was to repeat this process periodically, but to
date no sponsor has stepped forward.
QUALITY IMPROVEMENT
As noted above, traditional quality assurance (QA)
tends to focus on achieving a respectable level of perfor-
mance. A new genre of thinking about health care quality
came to prominence in the 1980s, drawing on the work of
industrial quality gurus, preeminently W. Edwards
Deming. Deming, a venerable thinker given much of the
credit for the Japanese post-war industrial revival, devel-
oped a “system of profound knowledge” that came to be
known as continuous quality improvement. His directives
include “improve every process” and “break down barri-
ers.” Manufacturing firms were the first demonstration
sites; health care, arguably, is still only partially on board.
As Merry describes it, “Continuous quality improve-
ment (QI) is first a mind-set and then a process. The
mind-set of traditional health care quality has been
reactive: ‘If it isn’t broken, don’t fix it.’ That of QI is
pro-active: ‘It may not be broken, but we can still
improve it.’” As Deming himself wrote, “Meeting
specifications is not enough.”8 While many people use
the terms interchangeably, QA and QI actually have
different orientations. QI looks forward, seeking ever-
better ways to improve upon the organization’s past
performance, while QA measures performance in
comparison to a predetermined threshold or floor.
QA and QI are not mutually exclusive; ideally, they
are complementary. QA’s focus is consumer protection
and individual accountability, which encourage a
competitive or regulatory—essentially external—
approach. QI seeks internal system improvement and
demands consultation and cooperation within an organi-
zation. QA can be used to cull bad apples and ensure
acceptable quality of care. QI operates in a higher
portion of the quality continuum, where organizations
and individuals are willing to commit the necessary
resources to move from acceptable to excellent.
For all the zeal of its proponents, QI has for some a
New Age aura of trendiness about it. Skeptics wonder
why, if QI is so wonderful, health care delivery has not
been transformed. Certain organizations with a long-term
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commitment to QI would say it that it has made a signifi-
cant difference in their own operations. For example,
Kaiser Permanente Colorado Region, with multiple care
facilities comprising the area’s oldest HMO, has estab-
lished a Regional Quality Resource Management Com-
mittee (RQRMC) to review aspects of the performance of
each clinical department and facility on an annual basis.
Each is required to define its scope of care and to identify
one or more important aspects of care within that scope to
work on during a given year. Projects culminate in a
detailed evaluation by the RQRMC, including assessment
of results and recommendations for next steps. (It should
be noted that selection of projects is influenced by data
collection requirements and priorities related to NCQA
accreditation and HEDIS).9
While QI programs vary in their scope and rigor,
organizational managements that have made a commit-
ment to such programs recognize in them a foundation
for the kind of systems redesign and team-think that
experts point to as the key to medical error reduction
and other improvements in patient care. In this concep-
tion, the market and the group’s own professionalism
push clinicians to improve, and QI programs give them
the tools to do so.
ROLES IN QUALITY ASSURANCE AND
IMPROVEMENT
Private Purchasers
Frustrated by years of double-digit inflation in health
benefits costs, employers fueled the transformation of
health care financing that has come to be called man-
aged care. Though cost containment was by far the
chief aim, some employers were keen to pursue value,
a concept incorporating both cost and quality. Before
the entire project was turned over to NCQA in 1992,
HEDIS was the creation of a group of large employers
(including Xerox, GTE, and Digital Equipment Corpo-
ration), who saw it as a means to standardize the
information they scrutinized in the contracting process.
U.S. automakers have been leaders in holding their
contracting health plans to performance standards. The
Buyers’ Health Care Action Group in Minnesota
experimented boldly with direct contracting with
providers.
Most recently, the Leapfrog Group, sponsored by the
Business Roundtable and comprising large employers
as well as business coalitions and liaison relationships
with the U.S. Office of Personnel Management and
HCFA, has undertaken an initiative to improve patient
safety. This is a voluntary program aimed at mobilizing
large purchasers “to alert the health care industry that
big leaps in patient safety and customer value will be
recognized and rewarded with preferential use and other
intensified market reinforcements.”10 A failure to
reward high-quality providers has been a shortcoming
many have pointed to in today’s health system, and the
Leapfrog move to align incentives with goals is a start
at redressing that failure. Whether rewarding by means
of “preferential use” (greater volume of patient refer-
rals) can be meaningful in an era of broad and overlap-
ping provider networks remains to be seen. However,
Leapfrog also emphasizes non-economic rewards such
as recognition, prestige, and press.
In a healthy economy with a hungry labor market,
employers would be likely to maintain or even improve
their benefit packages. But in conditions of economic
uncertainty, their behavior is less predictable—especially
since the cost relief initially achieved by turning to
managed care seems to have run its course.11 Small
employers have always struggled with the economics of
benefits coverage. Increasingly, large employers talk
about moving to a defined-contribution approach to
health benefits. So far it is mostly talk, but the
retirement-plan landscape, in which 401(k) plans have
long since supplanted defined-benefit plans, could be
read as a harbinger. On the other hand, some analysts
suggest that, since a fundamental change in health
insurance would have far more immediate impact than
a change in retirement plans, employees would resist it.
Under a defined-contribution model, employers
might provide comparative information to assist their
employees in choosing among plans, but their economic
spur to steer employees toward low-cost, high-quality
plans would be blunted. That is, once an employer
contribution level has been defined and paid, the
employer has no further financial responsibility, what-
ever plan the employee chooses. The lessening of
financial risk also calls into question employers’ stake
in continuing to hold health plans accountable for
quality markers such as NCQA accreditation.
Market enthusiasts have suggested that, if consumers
are spending their own money, they will be more cau-
tious and canny with respect to health-related expendi-
tures. This was the theory behind medical savings
accounts, which—in the limited demonstration autho-
rized by the Health Insurance Portability and Account-
ability Act of 1996—have not proved a hit with large
numbers of consumers. There is no evident groundswell
of consumers demanding to manage the details of their
health financing. However, if forced to shoulder more of
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the burden, consumers are likely to demand tools that
will help them make advantageous decisions.
Consumers already are interested in information
relating to their medical conditions. As they are made to
assume more responsibility for managing both their care
and their coverage, they will need some source to turn
to for reliable, understandable information about both
health plans and providers.
The Medical Profession
Common sense would suggest that physicians and
other providers would accept QA as a matter of course
and be first in line for QI. Several factors interfere with
this picture. First, there is the undeniable effect of
reimbursement incentives. Fee-for-service says, “Do
more and you will get paid more”; capitated managed
care says, “Do less and you will keep more.” Neither
says, “Do what is optimal for the patient and you will
be rewarded.”
A second obstacle is the tension between quality
improvement in a pure state, for the good of science and
mankind, and quality measurement interpreted as
accountability or “being told how to practice medicine.”
Physicians are conspicuously unenthusiastic about
answering to anyone but their peers, as witness the
battles with managed care organizations over who is
permitted to define what is medically necessary. And
regulation of physician practice is largely delegated to
the profession itself. That is, states have licensure
requirements, but obtaining one’s license is a one-time
event (like passing a bar exam) and any subsequent
disciplinary action is at the discretion of the state Board
of Medicine.
At the individual physician level, impediments to
quality improvement processes may be purely logistical.
Most physicians do not have a sufficient number of
patients presenting with a particular condition to
establish a typical practice pattern. Often, they lack an
accessible patient registry even to determine their
overall patient profile—for example, how many diabet-
ics are there in this group and how many would be
classified as severe?
Some health plans track the performance of physi-
cians or groups they contract with, allowing providers
to see how they compare to others in the plan. (Setting
mandatory levels generally is possible only where a
managed care plan has some means, such as contract
renewal, to enforce QA or QI requirements.) Some
medical groups provide the same feedback to their
member physicians.
Longer-term studies, requiring tracking of patients
over time, are apt to be disrupted by attrition. As a
physician states,
I’ve noticed that most of the patients that I was seeing
five or 10 years ago, I had been taking care of for 10
or 20 years. Now there’s a tremendous turnover of
patients related to people changing managed care
plans and, as a result, relationships are more superfi-
cial.12
Superficial doctor-patient relationships have com-
bined with media horror stories to erode public trust in
the medical profession. Widespread coverage of man-
aged care’s incentives to undertreat and of medical error
rates have made patients suspicious and doctors defen-
sive. And indeed doctors feel beleaguered from all
directions: patients they do not know and do not have
time to get to know; managed care plans with varying
rules, regulations, and predilections for second-guess-
ing; reporting requirements on the part of health plans
and states; seemingly endless paperwork; and so on.
The resulting siege mentality is not conducive to
teamwork or willingness to take on new projects.
The lion’s share of blame for all this has been laid at
the door of managed care. But physician efforts to wrest
destiny back into their own hands have not been notably
successful so far. A physician accreditation program
sponsored by the American Medical Association, billed
as a means of enabling the profession “to respond to the
demand for accountability for quality in health care,”
was eventually abandoned as overexpensive and
undersubscribed.13 The provider-sponsored organization
(PSO) was seen as a strong new model at the time the
Balanced Budget Act of 1997 (BBA) was enacted, but
PSOs have not materialized as significant Medicare+
Choice (M+C) contractors.14 Physician groups in parts
of California, having initially embraced capitation and
risk assumption, are finding managed care contracts
more onerous than anticipated. Even paperwork is not
strictly a burden imposed by HMOs, insurance compa-
nies, and HCFA; it is physicians, after all, who devel-
oped and still guard ownership of the very complex
coding systems used in making claims for services
provided.
State Government
State agencies play a variety of roles in measuring,
monitoring, and assuring health care quality. Most state
Medicaid agencies collect data on utilization, consumer
satisfaction, and disenrollment. Some states, such as
Arizona, Minnesota, and Massachusetts, have incorpo-
rated quality indicators and performance measures into
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their contracts with health plans. (From the health plan
perspective, this may mean more tailoring of data to
uncoordinated specifications; there is little consistency
across states.)
In addition, some state legislatures have created
health data organizations that collect and report certain
process and outcome measures of health care organiza-
tions across payers. Among these are the Pennsylvania
Health Care Cost Containment Council, which pub-
lishes comparative quality and cost reports on providers
(primarily hospitals); the Minnesota and Kansas Health
Data Institutes; and Maryland’s Health Care Access and
Cost Commission, which generates comparative plan
performance reports. Several states, including New
York and Virginia, make comparative hospital informa-
tion available on state Web sites.
As James Fossett and colleagues observed in an
article earlier this year, states may face hurdles in
promulgating and enforcing performance standards.
First, standards or benchmarks developed in the
commercial market may not transfer well to the
Medicaid population. Establishing these benchmarks
for local use may require considerable negotiation.
Second, quality reporting conventions and standards
are only partially standardized, so states wishing to
institute performance standards may need to invest
considerable effort and money in systems develop-
ment, negotiating over reporting conventions, and
auditing to ensure that reported data are comparable
and of reasonable quality.15
Federal Government
As both purchaser and regulator of a substantial
portion of the country’s health care, the federal govern-
ment has many avenues to influence the quality of that
care. The Departments of Defense and Veterans Affairs
determine the policies followed in their own facilities.
Other agencies exert influence via research dollars or
regulations. HCFA, the self-described “800-pound
gorilla,” is engaged in a variety of quality-related
initiatives. An interesting development in the past few
years has been the convening and activity of the Quality
Interagency Coordination Task Force (QuIC), the
mission of which is to ensure that all federal agencies
involved in purchasing, providing, studying, or regulat-
ing health care are working in harmony toward a
common goal of improving quality of care.
Medicare Conditions of Participation. In 1965, the
original Medicare legislation required hospitals to meet
certain requirements set forth in regulation as the
Medicare conditions of participation. These are struc-
tural criteria according to the Donabedian model, such
as staff qualifications, written policies and procedures,
governance, and record-keeping. These are now codi-
fied in hundreds of pages of federal regulation and
govern to a great extent the structural quality of U.S.
hospitals and health care facilities. The 1965 legislation
(in Section 1865 of the Social Security Act) also
provided that hospitals accredited by JCAHO would be
“deemed” to meet the conditions of participation; this
still prevails. It is perhaps worth noting that physicians
are not subject to any conditions of participation beyond
willingness to accept Medicare payment rates.
Peer Review Organizations/Quality Improvement
Organizations. Medicare costs grew rapidly after the
program’s enactment in 1965, raising questions about
what was being purchased and its value. In 1970, a
demonstration project assembled experimental Medi-
care care review organizations, voluntary associations
of physicians who reviewed services funded by Medi-
care and Medicaid. These became the model for the
professional standards review organizations (PSROs)
established by statute in 1972. PSROs were charged
with determining for reimbursement purposes whether
services were medically necessary, provided in accor-
dance with federal standards, and rendered in the
appropriate setting. Their activities included hospital
utilization review, development of hospital discharge
data, the conduct of medical care evaluation and quality
review studies, and the construction and analysis of
hospital and physician practice profiles.
When Medicare adopted prospective payment for
hospitals in 1983, the PSROs were replaced with peer
review organizations (PROs), which Congress envi-
sioned as a leaner and more efficient review mecha-
nism. Review areas were cut from 195 to 54, 1 for each
state and territory. Contracts were awarded on the basis
of competitive bidding rather than as grants, and their
funding cycle was lengthened to two (later three) years.
Administrative costs were to be paid from the Medicare
trust fund rather than through the appropriations pro-
cess. Where PSROs had to be physician-sponsored
organizations, PROs had the option to be physician-
access organizations, that is, organizations with a
sufficient number of physicians available to them to
ensure adequate review capability.16
PROs inherited from PSROs a set of sometimes
conflicting expectations. As an Institute of Medicine
analysis observed in 1990, Congress wanted a cost-
control program, PSROs thought they were in the
business of quality assurance, and HCFA was forced to
proceed as though PSROs could fulfill both functions.
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PROs have struggled with wearing both hats simulta-
neously but at least have managed to hang on to them
both. While cost control will never go out of fashion,
the PROs (who would prefer to be known as quality
improvement organizations) have successfully sustained
their QA/QI emphasis.
In 1992, HCFA and its contracting PROs launched
the Health Care Quality Improvement Program
(HCQIP), aimed at improving the health of Medicare
beneficiaries through bringing patterns of care into line
with evidence-based best practices. The initial focus
was acute myocardial infarction; in succeeding years
the effort has added five other clinical targets: breast
cancer, diabetes, heart failure, pneumonia, and stroke.
In addition, HCFA and the PROs have committed
themselves to reducing health (and treatment) dispari-
ties related to race, ethnicity, and gender within the
Medicare population. For the first time, HCFA has
instituted performance-based contracts with the PROs,
and will evaluate them based on improvements of
quality indicators.17 To accomplish their mission, PROs
actively seek collaboration with physicians, health care
facilities and local communities in their service areas.
Quality Measurement in Managed Care. While
PROs interact with Medicare providers across the
service delivery spectrum, most of HCFA’s quality
monitoring efforts have focused on managed care
contractors. BBA, which established a new Medicare
Part C to replace earlier risk contracting arrangements,
incorporated a number of quality requirements for M+C
contractors to fulfill. Critics have argued that managed
care plans face disproportionate scrutiny in comparison
with fee-for-service providers. But it was commercial
managed care plans, having embraced the notion of
accreditation, that offered a quality-measurement model
that HCFA could adapt.
A centerpiece of BBA’s quality provisions for
managed care plans was the Quality Improvement
System for Managed Care (QISMC). Participation is
mandatory for M+C plans and optional for states with
an interest in using this mechanism to assess Medicaid
quality. In summary, QISMC standards direct a man-
aged care organization to do the following:
 Operate an internal program of quality assessment
and performance improvement that achieves
demonstrable improvement in enrollee health,
functional status, and satisfaction across a broad
spectrum of care and services;
 Collect and report data reflecting its performance
on standardized measures of health care quality
and meet such performance levels on these mea-
sures as may be established under its contract
with HCFA or the state; and
 Demonstrate compliance with basic requirements
for administrative structures and operations that
promote quality of care and beneficiary protec-
tion.18
Work on QISMC standards actually began in 1996,
in advance of BBA. Standards were designed to build
on HCFA’s earlier Quality Assurance Reform Initiative
for Medicaid and on NCQA’s HEDIS. The initial draft
of QISMC standards was produced under a contract
with the National Academy for State Health Policy. The
academy reviewed standards used in both public and
private settings and circulated a QISMC standard draft
in January 1998. A set of standards and guidelines was
published in interim final form in September of that
year and was subsequently revised to reflect the M+C
final rule. New guidance for Medicare plans was
released in August 2000; an update for Medicaid plans
is forthcoming.
Reaction to the initial QISMC standards from M+C
plans and facilities was rancorous, along the lines of
“With everything else BBA is asking for, this is too
much.” Copious comments were taken into account in
the recent revision, in which HCFA attempted to
provide clarifications and some easing of the adminis-
trative burden on managed care plans. For example, the
statistical methodology for demonstrating beneficiaries’
health status improvement is now less arduous.19
The private sector had no well-established models
for measuring quality in a fee-for-service setting, and
in-house development of a fee-for-service performance
improvement program has been a long process. In
October 2000, HCFA researchers published a descrip-
tion of 24 initial quality measures and corresponding
baseline values measured by means of chart abstraction,
claims data, and surveys between 1997 and 1999.
Stephen F. Jencks and colleagues in HCFA’s Office of
Clinical Standards and Quality explain that their mea-
sures track most of the HEDIS clinical measures but
address more conditions and elements of care; they also
apply to the 85 percent of the Medicare population in
fee-for-service rather than to that portion in M+C plans.
Process measures were deliberately chosen, on the
grounds that (in comparison to outcomes) there is
greater consensus on appropriateness and it is easier for
providers to identify reasons that processes were not
carried out than to determine why outcomes are not
optimal. In addition, measuring processes of care
generally does not require the risk-adjustment that has
been so controversial in comparisons of outcomes.20
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The percentage of patients reported as having
received appropriate care ranged from a high of 95
percent to a low of 11 percent. As noted above, PRO
contracts include requirements to improve statewide
performance on the measures over the three years of
their contract cycle.
Deeming Authority for Managed Care Quality. BBA
gave HCFA the authority to create a program allowing
private, nationally recognized accrediting bodies to
deem that an M+C organization is in compliance with
certain Medicare requirements. An accrediting body
may apply for approval to deem M+C plans in compli-
ance in six performance areas: quality assurance, access
to services, provider participation rules, information on
advance directives, antidiscrimination, and confidential-
ity and accuracy of enrollee records. The accrediting
body is not required to apply for all six areas, nor will
HCFA necessarily approve applications in all areas.
As mentioned above, it is long-established practice
to deem that hospitals achieving JCAHO accreditation
automatically meet Medicare standards. Deeming
distills the larger policy question of contracting out
government regulatory services to organizations that
then operate with quasi-governmental authority. It also
raises a concern about a conflict of interest when an
organization originally founded for the benefit of a
group (such as hospitals) later becomes its regulator.
Managed care organizations, many of which seek
private accreditation in any case, believe that deeming
will reduce duplicative compliance efforts and expense.
On the other side, making use of an accrediting body’s
surveyors and analysts clearly enhances HCFA’s moni-
toring capacity. However, if a problem comes to light in
an accredited M+C organization, HCFA rather than the
accrediting body retains the ultimate responsibility.
Expanded deeming authority may facilitate the
standardization of quality measures. It also signals a
federal willingness to align with private-sector employ-
ers, although not perhaps as closely as some might
wish. While indicating NCQA’s intent to pursue
deeming authority, the organization’s president,
Margaret O’Kane, has expressed disappointment that
there are many specific HCFA requirements that NCQA
standards at present meet only partially or not at all.21
The reverse is also the case, in that NCQA has stan-
dards beyond those that HCFA contemplates.
AHRQ. Pursuing quality on another front within the
Department of Health and Human Services is AHRQ.
Where HCFA is purchaser and regulator, AHRQ is
researcher, coordinator, and translator. That is, the
agency funds research on quality measurement and
outcomes and then seeks to make research findings
accessible to a variety of health care stakeholders,
including clinical decision-makers, health care systems
leaders, and policymakers. AHRQ-funded research
vehicles include the following:
 Evidence-based practice centers—12 consortia of
clinical and methodological experts that develop
evidence reports and technological assessments on
clinical topics that are common, expensive, and/or
significant to the Medicare and Medicaid populations.
 Patient outcomes research teams—large multi-site
projects that focus on specific conditions, such as
stroke and pneumonia.
 Centers for education and research in therapeutics,
which focus on appropriate and effective use of
drugs and drug combinations with other forms of
intervention.
In addition, AHRQ maintains numerous databases,
including the National Guideline Clearinghouse men-
tioned earlier, the Computerized Needs-Oriented
Quality Measurement Evaluation System
(CONQUEST), the Healthcare Cost and Utilization
Project (known as HCUP), and the Medical Expendi-
ture Panel Survey (MEPS). HCUP quality indicators
furnish software developed for use with hospital admin-
istrative data, which are used by many states to assess
hospital care quality.
Public-Private Partnerships
In many ways, AHRQ deliberately tries to serve as
the fulcrum of a public-private partnership, bringing
together academics, businesses, health care providers,
government agencies, and consumers. Such broad-
based collaborations can be unwieldy but have the
intrinsic advantage of getting stakeholders at the same
table.
Another public-private effort is the National Forum
for Health Care Quality Measurement and Reporting,
more familiarly the Quality Forum. This group arose
from a recommendation made by the President’s
Advisory Commission on Consumer Protection and
Quality in its 1998 report. It was incorporated in the
District of Columbia in May 1999 with initial funding
from the federal government and foundations.
The Quality Forum’s mission statement defines it
as a “private, nonprofit entity that will develop a
comprehensive quality measurement and public
reporting strategy that addresses priorities for quality
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measurement consistent with national aims for quality
improvement in health care.” To this end, the organi-
zation has formed both a board of directors and what
is called the Strategic Framework Board, a group of
recognized health policy experts who have agreed to
devote 20 percent of their time to developing a na-
tional quality measurement and reporting strategy. The
board has composed a purpose statement to guide its
activities and intends to formulate national quality
goals focused on clinical conditions that are prevalent
or carry a high risk of disability, suffering, or death.
As of December, the Quality Forum had 107 mem-
bers (ranging from medical specialty societies to large
employers to trade associations). President Kenneth W.
Kizer, M.D., reported last fall that dues income at one
year exceeded projections by more than 50 percent.22
Nevertheless, some observers have been disappointed
in the Quality Forum’s low profile and fear that policy
experts talking amongst themselves is another variation
on preaching to the choir.
The Institute of Medicine’s Committee on the Quality
of Health in America is a group representing health care
providers, consumers, and researchers as well as insurers,
employers, and the press. Its hugely influential 1998
report, To Err Is Human, now has a sequel, Crossing the
Quality Chasm. This report says flatly, “The current care
systems cannot do the job. Trying harder will not work”
—but also presents a series of recommendations to
transform current systems so that all Americans can count
on receiving care that meets their needs and is based on
the best available scientific knowledge.23
Consumers
Americans treasure choice, in everything from soft
drinks to television channels to pediatricians. Much of
the ire directed at managed care organizations in recent
years stemmed from restrictions on the ability to choose
one’s own doctor. If a person has a choice of health
plans and of providers, the reasoning goes, he or she
will be able to select benefits and relationships that
meet his or her needs. Similarly, if given information on
quality, people will factor it into their decisions, as they
do when consulting Consumer Reports to research the
purchase of a refrigerator.
One of the fundamental tenets of managed care in its
early days was that people would choose among com-
peting plans on the basis of their networks of providers
and their service as well as their price. In practice, it has
remained employers’ responsibility to make an initial
selection of plans; employees may or may not be
offered multiple options. Ninety-two percent of workers
in firms with more than 5,000 employees have a choice
among plans, though this may mean a choice among
different products offered by the same plan. Only 24
percent of those in firms with fewer than 200 employees
report more than one option.24 Without free choice,
comparative information at the plan level has little
effect on selection behavior.
Americans do, by and large, choose their own
doctors and—depending on physician affiliation—
hospitals. Even if they are choosing from a list of
network providers, there is some scope for personal
preference. But comparative information about physi-
cians, which is compiled by some more sophisticated
medical groups, is used mostly to assess physician
performance and is not typically shared with patients.
Some health plans, such as PacifiCare, have published
comparative information at the medical group level, but
this is largely a California phenomenon.
Hospital comparisons are not available in most
markets and remain controversial where they do exist.
Public agencies that have published hospital perfor-
mance reports (for example, the Health Care Financing
Administration and Pennsylvania’s Health Care Cost
Containment Council) have faced vociferous criticism
from providers, who assert that performance measures
do not adequately reflect severity-of-illness differences.
Cleveland Health Quality Choice, a private, employer-
led effort, was forced to close its doors when the city’s
most prominent hospital system refused any further
cooperation in comparative data-gathering. Absent a
universally acceptable risk-adjustment mechanism, one
that fairly accounts for differing caseload risk, such
resistance is likely to continue.
Some have suggested that the best way to hold
providers accountable to consumers is to educate and
empower consumers to take a more effective part in
their own treatment. Ideally, such a learning process
would occur before a person became ill, but in many
cases interest is likely to be sparked only after there is
something to worry about. Consumer-education
initiatives exist, though their impact to date is debat-
able. HCFA, for example, has established a Center for
Beneficiary Services, whose primary focus is educa-
tional. A private group, the Foundation for Account-
ability (FACCT) is committed to measuring health
care quality and communicating results in a way that
makes sense to consumers.25 Numerous Web sites, in
addition to FACCT’s, have been established, both as
commercial ventures and by patient associations. The
latter tend to be disease-specific, aimed at fellow
sufferers.
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In a September 2000 speech to members of the
Leapfrog Group, FACCT president David Lansky made
an eloquent case for turning to consumers as the neces-
sary drivers of quality improvement. FACCT-sponsored
focus groups have revealed that consumers believe they
know the difference between high- and low-quality
care, that they think of themselves as customers and are
willing to take action to get the care they require, but
also that they recognize they need tools and support
(from other consumers, advocates, and employers) in
order to be effective.
Lansky suggests that consumers can be mobilized,
given that health care is personal and emotional and
that, increasingly, consumers do not feel they can trust
anyone else to look out for their best interests. Among
messages FACCT has tested, those measured most
effective have appealed to fear (of medical errors, for
instance) and distrust and have emphasized personal
responsibility and the need for collective action.
If this empowered-consumer scenario plays out,
what will the individual need in order to be his own
champion? Paul Elwood, M.D., a primary HMO
progenitor who has come to embrace a consumer-
centered vision of health care reform, suggests starting
with three services packaged as a Web-based module:
 to Coaching: providing elementary information
necessary to manage one’s illness or health needs,
tailored to particular conditions.
 Comparing: personalized feedback to assess one’s
quality of care.
 Choosing: assistance in selecting a health plan,
doctor, or system of care.26
A central tenet of the empowered-consumer strategy
is that consumers must move into partnership relation-
ships with their physicians, accepting (or insisting on)
an equal role in decisions about their own care.
INTO THE NEXT ERA
Efforts to improve health care quality seem to have
taken all the available routes in the last decade or two.
There have been provider-based practice guidelines and
bonus pools tied to quality measurement. Regulatory
and private accrediting bodies have established stan-
dards and publicized performance in relation to them.
The market has had its shot with managed care con-
tracting. Dot-com entrepreneurs have seized on the
need for health care information. And still, in Septem-
ber 2000, USA Today can sport the front-page headline,
“The operation you get often depends on where you
live,” atop an article based on the Dartmouth Atlas of
Health series and quoting John Wennberg, M.D., who
has drawn attention to regional variation for 30 years.27
Can policymakers look to consumers to galvanize
what has been a long, slow, technical process? Clearly,
further education is needed if consumers are to be able
to distinguish gradations in clinical quality or to sepa-
rate quality from convenience. A recent Kaiser Family
Foundation/AHRQ survey found consumers concerned
about medical errors and desirous of more provider-
based information. But even the best-educated, most
judiciously scientific consumer may veer into the realm
of emotion when his own life or that of a loved one
appears to be at stake.
A number of legislators, wishing to move quality
efforts forward at a faster pace, have introduced bills to
encourage or demand improvement. In the wake of the
Institute of Medicine’s much-publicized report on
medical errors, for example, Sen. James Jeffords (R-
Vt.) introduced a proposal to amend the Public Health
Service Act to reduce medical mistakes and medication-
related errors. Rep. Pete Stark (D-Calif.) adduced the
same report in his statement introducing (with others) a
bill to establish quality of care and safety as a major
emphasis in Medicare. Other proposals are under
consideration in the 107th Congress. However, their
authors would probably agree that no one really knows
how to write a bill to compel culture change of the kind
that is needed to achieve the transition into the next
generation of health care in America.
There are some issues that no one stakeholder can
resolve. For example, philosophically, does responsibility
for quality ultimately come from within—through the
professional and ethical commitment of providers—or
from without—through the urgings or proscriptions of
purchasers or the enforcement power of government?
Practically, how do we recognize and value the process of
collecting, analyzing, and disseminating data?
The prospect can be discouraging. But there has
been visible progress: measuring results rather than
capabilities, sharing information more widely. Quality-
promoting strategies such as systems thinking and
action steps such as computerized prescription entry are
becoming more prevalent. And improving health care
quality is an aim that unites all camps. What remains to
be seen is what organization(s) or leader(s) can achieve
critical mass—and the commitment of resources—to
launch a quality improvement snowball.
 14 
1. Joint Commission on Accreditation of Healthcare Organi-
zations, Joint Commission History factsheet, January 1998.
2. Martin D. Merry, “ The Evolution of Quality Assurance
and an Overview of TQM”; accessed August 15, 2000, at
http://www.nhgmaine.com.
3. Michael Wolk, quoted in “1999 Annual Report: A Decade
of Quality Work,” National Committee for Quality Assur-
ance, Washington, D.C., 5.
4. National Committee for Quality Assurance, “NCQA
Overview: Measuring the Quality of America’s Health Care”;
accessed August 16, 2000, at http://www.ncqa.org/
Pages/Communications/Publications/ncqaoverview.pdf , 4.
5. Jon R. Gabel et al., “Employer Health Benefits: 1999
Annual Survey,” Henry J. Kaiser Foundation and Health
Research and Educational Trust, Chicago, 1999.
6. Agency for Healthcare Research and Quality, “CAHPS:
Consumer Assessment of Health Plans”; accessed July 10,
2000, at http:// www.ahrq.gov/qual/cahps/.
7. Agency for Healthcare Research and Quality, Research
Activities, Washington, D.C., September 2000, 12.
8. W. Edward Demings; accessed November 28, 2000, at
http://www.deming.org.
9. For a more detailed case study, see Sally Coberly,
“Regional Quality Resource Committee,” in Managing Care,
Operations, and Performance (Washington, D.C.: Washing-
ton Business Group on Health, 1998).
10. Leapfrog Group for Patient Safety; accessed November
29, 2000, http://www.leapfroggroup.org.
11. The Kaiser Family Foundation-Health Research and
Educational Trust survey mentioned above found that firms
averaged a 4.8 percent premium increase in 1999; at 8.3
percent, Kaiser’s figure for the average increase in 2000 is
nearly double.
12. Wolk, “1999 Annual Report,” 8.
13. Linda O. Prager, “AMAP’s Demise Leaves Void in
Physician Evaluation,” American Medical News, March 27,
2000.
14. See Nora Super Jones, “Medicare+Choice: Where to from
Here?” NHPF Issue Brief No.758, September 8, 2000.
15. James W. Fossett et al., “Managing Medicaid Managed
Care: Are States Becoming Prudent Purchasers?” Health
Affairs, 19, no. 4 (July/August 2000), 4.
16. Beth C. Fuchs, “Medicare’s Peer Review Organizations,”
Congressional Research Service, Washington, D.C., June 13,
1990, 3-4.
17. Health Care Financing Administration, “Medicare's
Health Care Quality Improvement Program v5-2"; accessed
August 31, 2000, at http://www.hcfa.gov/quality.
18. Health Care Financing Administration, “Operational
Policy Letter #72"; accessed September 28, 2000, at http://
www.hcfa.gov/quality/medicare/opl072.htm.
19. “HCFA Continues Easing Admin. Rules for M+C Plans
with New QISMC Guidance,” News and Strategies for
Managed Care and Medicaid, September 4, 2000,1, 6.
20. Stephen F. Jencks, “Quality of Medical Care Delivered to
Medicare Beneficiaries,” Journal of the American Medical
Association, 284, no.13 (October 4, 2000): 1670-76.
21. Margaret E. O’Kane, testimony presented to the Medicare
Payment Advisory Commission, September 15, 2000.
22. National Quality Forum, “President’s Corner”; accessed
April 11, 2001, at http://www.qualityforum.org/prescorner/
home.htm.
23. Institute of Medicine, Crossing the Quality Chasm
(Washington, D.C.: National Academy Press, 2001), 4.
24. Jon R. Gabel et al., “Employer Health Benefits: 2000
Annual Survey,” Henry J. Kaiser Foundation and Health
Research and Educational Trust, Chicago, 2000.
25. Foundation for Accountability, “Supporting Quality-
Based Decisions”; accessed April 12, 2001, at
http://www.facct.org.
26. Paul M. Elwood, “A Deconstructionist’s View of Man-
aged Care,” NASCHIP News, Summer 2000, 7.
27. Dan Vergano, “The Operation You Get Often Depends on
Where You Live,” USA Today, September 19, 2000.
ENDNOTES
